Carlos Pittol has a diverse work experience spanning over several years. Carlos started their career as a Senior Projects Manager at Oakland Innovation & Information Services in 1995. In 1998, they moved on to become a Biotechnology Analyst at Clubb BioCapital Ltd. Carlos then joined CLUBB CAPITAL LIMITED in 2003 as a Director. Carlos then became the Chief Operating Officer at Pangaea Group in 2017. Since 2011, they have been associated with Antikor Biopharma Ltd, where they served as a Non-Executive Director from 2011 to 2019 and currently holds the position of Business Development Manager.
Carlos Pittol has a diverse education history. Carlos obtained a Diploma in Investment Compliance from The Chartered Institute for Securities & Investment (The CISI) in 2010. Prior to that, they pursued an M.Phil. degree in International Relations from the University of Cambridge in 1994. Carlos also undertook a PENCE Post-Doctoral Research Fellowship in Chemistry at the University of Toronto from 1992 to 1994.
Carlos Pittol holds a Ph.D. in Organic Chemistry, which they earned from the University of Exeter in 1992. Carlos previously completed their undergraduate studies at the same institution, obtaining a B.Sc. in Chemistry in 1988. Additionally, they attended the Vienna International School, although specific details such as dates and degrees are not provided.
In terms of additional certifications, Carlos Pittol completed a course titled "Sheryl Sandberg and Adam Grant on Option B: Building Resilience" through LinkedIn in April 2020. Carlos also became a Fellow Chartered Chemist of the Royal Society of Chemistry in March 2021.
Sign up to view 0 direct reports
Get started
This person is not in any teams